Close Menu

At the annual meeting of the Association for Molecular Pathology in Texas this week, the BC Cancer Agency's David Huntsman said that not only is next-generation sequencing changing the paradigm of cancer treatment, but that pathologists can and should use this technology to tease apart cancer's complexity and shed light on the various causes and avenues of treatment. Next-gen sequencing is the first truly disruptive technology for diagnostics since the introduction of the microscope in the 1850s, Huntsman said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

In Science this week: chromatin accessibility of microglia during fetal development, and more.